Interestingly, we found that PBC patients with NAFLD had lower levels of serum ALB<LLN, PLT<LLN, and cirrhosis, but higher rates of hypercholesterolemia and survival. The gene discussed is ALB; the disease is metabolic dysfunction-associated steatotic liver disease.